{"id":"NCT02891070","sponsor":"Baxter Healthcare Corporation","briefTitle":"Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery","officialTitle":"A Randomised Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated FS VH S/D 500 S-apr (Tisseel) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10-11","primaryCompletion":"2018-08-22","completion":"2018-08-22","firstPosted":"2016-09-07","resultsPosted":"2019-09-10","lastUpdate":"2019-09-10"},"enrollment":224,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Cerebrospinal Fluid Leak"],"interventions":[{"type":"DRUG","name":"FS VH S/D 500 s-apr","otherNames":["Tisseel"]},{"type":"DEVICE","name":"DuraSeal Dural Sealant","otherNames":[]}],"arms":[{"label":"FS VH S/D 500 s-apr","type":"EXPERIMENTAL"},{"label":"DuraSeal Dural Sealant","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this study is to evaluate the safety and efficacy of FS VH S/D 500 s-apr for use as an adjunct to sutured dural repair in cranial surgery.","primaryOutcome":{"measure":"Number of Participants With No CSF Leak During and After Surgery","timeFrame":"Day 0 (Intra-operative) to Day 30 (+/-3 days) post-operative","effectByArm":[{"arm":"Tisseel","deltaMin":76,"sd":null},{"arm":"DuraSeal","deltaMin":87,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":25,"countries":["United States","Czechia","Germany","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":110},"commonTop":["Headache","Pain","Nausea","Vomiting","Constipation"]}}